- Home
- NEO vs DFIN Comparison
NEO vs DFIN Comparison
Compare NEO & DFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NEO | DFIN |
|---|---|---|
| Founded | 2001 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 1999 | N/A |
Fundamental Metrics
Financial Performance| Metric | NEO | DFIN |
|---|---|---|
| Price | $11.87 | $46.01 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 2 |
| Target Price | $12.56 | ★ $63.50 |
| AVG Volume (30 Days) | ★ 1.8M | 260.4K |
| Earning Date | 10-28-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.12 |
| Revenue | $709,162,000.00 | ★ $750,800,000.00 |
| Revenue This Year | $10.90 | N/A |
| Revenue Next Year | $9.88 | $4.20 |
| P/E Ratio | ★ N/A | $40.86 |
| Revenue Growth | ★ 10.10 | N/A |
| 52 Week Low | $4.72 | $37.80 |
| 52 Week High | $19.12 | $69.93 |
Technical Indicators
Market Signals| Indicator | NEO | DFIN |
|---|---|---|
| Relative Strength Index (RSI) | 60.77 | 43.62 |
| Support Level | $11.59 | $45.00 |
| Resistance Level | $12.26 | $46.80 |
| Average True Range (ATR) | 0.42 | 1.30 |
| MACD | -0.07 | -0.03 |
| Stochastic Oscillator | 49.80 | 20.66 |
Price Performance
Historical ComparisonAbout NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
About DFIN Donnelley Financial Solutions Inc.
Donnelley Financial Solutions Inc is a risk and compliance solutions company. The company provides regulatory filing and deal solutions via its software-as-a-service, technology-enabled services, and print and distribution solutions to public and private companies, mutual funds, and other regulated investment firms. The company operates in four segments: Capital Markets - Software Solutions, Capital Markets - Compliance and Communications Management, Investment Companies - Software Solutions and Investment Companies - Compliance and Communications Management. Its geographical segments are the United States( USA), Europe, Asia, Canada, and others, of which the USA accounts for the vast majority of its total revenue.